KZA 0.80% $1.26 kazia therapeutics limited

Novogen AFR article

  1. 3,567 Posts.



    Shares in the pharmaceutical developer continued to gain on Thursday, taking the stock's total gains to 65 per cent over the last 2 weeks. It was assisted on Tuesday when Novogen announced a lower than expected loss of $14.7 million. By early afternoon Novogen had risen 20¢, or 10 per cent, to $2.02, gaining momentum from a positive company report to shareholders outlining the development progress of its family of anti-cancer drugs with US company Marshall Edwards. Novogen said its Phenoxodiol ant-cancer drug had completed Phase 1 clinical trial successfully and was moving into Phase 2.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Mkt cap ! $165.6M
Open High Low Value Volume
$1.29 $1.30 $1.25 $18.39K 14.46K

Buyers (Bids)

No. Vol. Price($)
2 2187 $1.25

Sellers (Offers)

Price($) Vol. No.
$1.26 3215 3
View Market Depth
Last trade - 12.26pm 30/07/2021 (20 minute delay) ?
0.010 ( 1.19 %)
Open High Low Volume
$1.25 $1.25 $1.25 1813
Last updated 13.02pm 30/07/2021 (live) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.